
Same stock, slightly less champagne
RBC took a little froth off IBM’s valuation story, slicing its price target to $330 from $361. But before you start panicking, it kept an Outperform rating, which is Wall Street’s way of saying: “We still like this thing, just maybe not enough to throw a parade.”
What that means for your portfolio
For IBM holders, this is more a haircut than a head shave. The stock can still get love from analysts even when the target comes down — especially in a name like IBM, where the debate is often less “is this company alive?” and more “how much can this old-school giant still squeeze out of cloud, software, and services?”
The bigger vibe check
The move also lands in a very IBM kind of week: the company has been getting its fair share of analyst attention ahead of earnings, with multiple firms tweaking targets and expectations. So if you’re watching the name, this is another data point in the pre-earnings tug-of-war between optimism and valuation nerves.
Big picture
RBC didn’t exactly slam the brakes here. It just lowered the speed limit a bit while still telling you to keep driving.
